304 related articles for article (PubMed ID: 26010877)
1. Association of plasma adipokines with chronic obstructive pulmonary disease severity and progression.
Oh YM; Jeong BH; Woo SY; Kim SY; Kim H; Lee JH; Lim SY; Rhee CK; Yoo KH; Lee JH; Yoon HK; Sin DD; Lee SD; Kim EK; Park HY;
Ann Am Thorac Soc; 2015 Jul; 12(7):1005-12. PubMed ID: 26010877
[TBL] [Abstract][Full Text] [Related]
2. Lower leptin/adiponectin ratio and risk of rapid lung function decline in chronic obstructive pulmonary disease.
Suzuki M; Makita H; Östling J; Thomsen LH; Konno S; Nagai K; Shimizu K; Pedersen JH; Ashraf H; Bruijnzeel PL; Maciewicz RA; Nishimura M; ;
Ann Am Thorac Soc; 2014 Dec; 11(10):1511-9. PubMed ID: 25372271
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin is associated with dynamic hyperinflation and a favourable response to inhaled glucocorticoids in patients with COPD.
Leivo-Korpela S; Lehtimäki L; Vuolteenaho K; Nieminen R; Kööbi L; Järvenpää R; Kankaanranta H; Saarelainen S; Moilanen E
Respir Med; 2014 Jan; 108(1):122-8. PubMed ID: 24135487
[TBL] [Abstract][Full Text] [Related]
4. Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers.
Krommidas G; Kostikas K; Papatheodorou G; Koutsokera A; Gourgoulianis KI; Roussos C; Koulouris NG; Loukides S
Respir Med; 2010 Jan; 104(1):40-6. PubMed ID: 19782551
[TBL] [Abstract][Full Text] [Related]
5. Serum ghrelin and adiponectin levels are increased but serum leptin level is unchanged in low weight Chronic Obstructive Pulmonary Disease patients.
Uzum AK; Aydin MM; Tutuncu Y; Omer B; Kiyan E; Alagol F
Eur J Intern Med; 2014 Apr; 25(4):364-9. PubMed ID: 23523152
[TBL] [Abstract][Full Text] [Related]
6. The serum levels of adiponectin and leptin in mustard lung patients.
Rokni Yazdi H; Lari SM; Attaran D; Ayatollahi H; Mohsenizadeh A
Hum Exp Toxicol; 2014 Jun; 33(6):574-81. PubMed ID: 24064910
[TBL] [Abstract][Full Text] [Related]
7. The association of metabolic syndrome with adipose tissue hormones and insulin resistance in patients with COPD without co-morbidities.
Minas M; Kostikas K; Papaioannou AI; Mystridou P; Karetsi E; Georgoulias P; Liakos N; Pournaras S; Gourgoulianis KI
COPD; 2011 Dec; 8(6):414-20. PubMed ID: 22149401
[TBL] [Abstract][Full Text] [Related]
8. The association of adiponectin with computed tomography phenotypes in chronic obstructive pulmonary disease.
Carolan BJ; Kim YI; Williams AA; Kechris K; Lutz S; Reisdorph N; Bowler RP
Am J Respir Crit Care Med; 2013 Sep; 188(5):561-6. PubMed ID: 23777323
[TBL] [Abstract][Full Text] [Related]
9. The relationship between adipokines, body composition, and bone density in men with chronic obstructive pulmonary disease.
Vondracek SF; Voelkel NF; McDermott MT; Valdez C
Int J Chron Obstruct Pulmon Dis; 2009; 4():267-77. PubMed ID: 19657401
[TBL] [Abstract][Full Text] [Related]
10. [Lessons from the Hokkaido COPD cohort study].
Nishimura M; Makita H
Nihon Rinsho; 2016 May; 74(5):864-8. PubMed ID: 27254960
[TBL] [Abstract][Full Text] [Related]
11. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease.
Nishimura M; Makita H; Nagai K; Konno S; Nasuhara Y; Hasegawa M; Shimizu K; Betsuyaku T; Ito YM; Fuke S; Igarashi T; Akiyama Y; Ogura S;
Am J Respir Crit Care Med; 2012 Jan; 185(1):44-52. PubMed ID: 22016444
[TBL] [Abstract][Full Text] [Related]
12. Assessment of leptin and resistin levels in patients with chronic obstructive pulmonary disease.
Kumor-Kisielewska A; Kierszniewska-Stępień D; Pietras T; Kroczyńska-Bednarek J; Kurmanowska Z; Antczak A; Górski P
Pol Arch Med Wewn; 2013; 123(5):215-20. PubMed ID: 23611920
[TBL] [Abstract][Full Text] [Related]
13. Systemic and airway inflammation and the presence of emphysema in patients with COPD.
Papaioannou AI; Mazioti A; Kiropoulos T; Tsilioni I; Koutsokera A; Tanou K; Nikoulis DJ; Georgoulias P; Zakynthinos E; Gourgoulianis KI; Kostikas K
Respir Med; 2010 Feb; 104(2):275-82. PubMed ID: 19854037
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease.
Kirdar S; Serter M; Ceylan E; Sener AG; Kavak T; Karadağ F
Scand J Clin Lab Invest; 2009; 69(2):219-24. PubMed ID: 18946779
[TBL] [Abstract][Full Text] [Related]
15. Queens beat one-eyed jacks, but nobody's played the ace yet. Adipokines as chronic obstructive pulmonary disease biomarkers.
Curtis JL
Ann Am Thorac Soc; 2015 Jul; 12(7):971-3. PubMed ID: 26203606
[No Abstract] [Full Text] [Related]
16. Decreased serum transforming growth factor-β1 concentration with aging is associated with the severity of emphysema in chronic obstructive pulmonary disease.
Kamio K; Ishii T; Motegi T; Hattori K; Kusunoki Y; Azuma A; Gemma A; Kida K
Geriatr Gerontol Int; 2013 Oct; 13(4):1069-75. PubMed ID: 23441714
[TBL] [Abstract][Full Text] [Related]
17. Relationship between plasma matrix metalloproteinase levels, pulmonary function, bronchodilator response, and emphysema severity.
Koo HK; Hong Y; Lim MN; Yim JJ; Kim WJ
Int J Chron Obstruct Pulmon Dis; 2016; 11():1129-37. PubMed ID: 27313452
[TBL] [Abstract][Full Text] [Related]
18. [Adipose tissue hormones and nutritional status in chronic obstructive pulmonary disease].
Nevzorova VA; Barkhatova DA; Kudriavtseva VA; Luk'ianov PA
Ter Arkh; 2009; 81(12):54-8. PubMed ID: 20481051
[TBL] [Abstract][Full Text] [Related]
19. [Circulating leptin and ghrelin in patients with chronic obstructive pulmonary disease].
Peng M; Cai BQ; Ma Y; Zhu HJ; Sun Q; Song AL
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):182-5. PubMed ID: 17572996
[TBL] [Abstract][Full Text] [Related]
20. CHRNA3 variant for lung cancer is associated with chronic obstructive pulmonary disease in Korea.
Kim WJ; Oh YM; Kim TH; Lee JH; Kim EK; Lee JH; Lee SM; Shin TR; Yoon HI; Lim SY; Lee SD
Respiration; 2013; 86(2):117-22. PubMed ID: 23207642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
